Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe

References

• Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother 2012; 8:81-8; PMID:22252006; http://dx.doi.org/10.4161/hv.8.1.17623
   PubMed Web of Science ®Google Scholar
• Mazick A, Gergonne B, Nielsen J, Wuillaume F, Virtanen MJ, Fouillet A, Uphoff H, Sideroglou T, Paldy A, Oza A, et al. Excess mortality among the elderly in 12 European countries, February and March 2012. Euro Surveill 2012; 17; PMID:22516003
   PubMedGoogle Scholar
• Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 2008; 8:44-52; PMID:18156088; http://dx.doi.org/10.1016/S1473-3099(07)70311-0
   PubMed Web of Science ®Google Scholar
• Paget WJ, Balderston C, Casas I, Donker G, Edelman L, Fleming D, Larrauri A, Meijer A, Puzelli S, Rizzo C, et al. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr 2010; 169:997-1008; PMID:20229049; http://dx.doi.org/10.1007/s00431-010-1164-0
   PubMed Web of Science ®Google Scholar
• Nokleby H, Nicoll A. Risk groups and other target groups - preliminary ECDC guidance for developing influenza vaccination recommendations for the season 2010–11. Euro Surveill 2010; 15(12):19525; PMID:20350496
   PubMedGoogle Scholar
• Kuster SP, Shah PS, Coleman BL, Lam PP, Tong A, Wormsbecker A, McGeer A. Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis. PLoS One 2011; 6:e26239; PMID:22028840; http://dx.doi.org/10.1371/journal.pone.0026239
   PubMed Web of Science ®Google Scholar
• WHO Influenza Factsheet 211: Prevention and control of influenza pandemics and annual epidemics. World Health Organisation, 2012. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/. (Last access: 11/24/2015).
   Google Scholar
• Revised estimates of deaths associated with seasonal influenza in the US. European Centre for Disease Prevention and Control, 2010. Available from: http://ecdc.europa.eu/en/activities/sciadvice/_layouts/forms/Review_DispForm.aspx?List=a3216f4c-f040-4f51-9f77-a96046dbfd72&ID=394. (Last access: 11/24/2015).
   Google Scholar
• European Centre for Disease Prevention and Control. Factsheet for health professionals. Available from: http://ecdc.europa.eu/en/healthtopics/seasonal_influenza/basic_facts/Pages/factsheet_professionals_seasonal_influenza.aspx. (Last access: 11/24/2015).
   Google Scholar
• Ryan J, Zoellner Y, Gradl B, Palache B, Medema J. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine 2006; 24:6812-22; PMID:17034909; http://dx.doi.org/10.1016/j.vaccine.2006.07.042
   PubMed Web of Science ®Google Scholar
• Keech M, Scott AJ, Ryan PJ. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med (Lond) 1998; 48:85-90; PMID:9614766; http://dx.doi.org/10.1093/occmed/48.2.85
   PubMed Web of Science ®Google Scholar
• Keech M, Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics 2008; 26:911-24; PMID:18850761; http://dx.doi.org/10.2165/00019053-200826110-00004
   PubMed Web of Science ®Google Scholar
• Commission of the European Communities. Proposal for a Council recommendation on seasonal influenza vaccination. Brussels; Commission of the European Communities; 2009. Available from: http://ec.europa.eu/health/ph_threats/com/Influenza/docs/seasonflu_rec2009_en.pdf. (Last access: 11/24/2015).
   Google Scholar
• Caini S, Huang QS, Ciblak MA, Kusznierz G, Owen R, Wangchuk S, Henriques CM, Njouom R, Fasce RA, Yu H, et al. Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study. Influenza Other Respir Viruses 2015; 9(Suppl 1):3-12; PMID:26256290; http://dx.doi.org/10.1111/irv.12319
   PubMed Web of Science ®Google Scholar
• Harvala H, Smith D, Salvatierra K, Gunson R, von Wissmann B, Reynolds A, Frew C, MacLean A, Hunt A, Yirrell D, et al. Burden of influenza B virus infections in Scotland in 2012/13 and epidemiological investigations between 2000 and 2012. Euro Surveill 2014; 19; PMID:AMBIGUOUS
   PubMedGoogle Scholar
• Heikkinen T, Ikonen N, Ziegler T. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999–2012. Clin Infect Dis 2014; 59:1519-24; PMID:25139969; http://dx.doi.org/10.1093/cid/ciu664
   PubMed Web of Science ®Google Scholar
• Mosnier A, Caini S, Daviaud I, Bensoussan JL, Stoll-Keller F, Bui TT, Lina B, Van der Werf S, Cohen JM; GROG network. Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003–2013. BMC Infect Dis 2015; 15:357; PMID:26289794; http://dx.doi.org/10.1186/s12879-015-1056-z
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Influenza activity–United States and worldwide, 2007–08 season. MMWR Morb Mortal Wkly Rep 2008; 57:692-7; PMID:18583957
   PubMedGoogle Scholar
• Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010:CD001269; PMID:20614424
   PubMed Web of Science ®Google Scholar
• Lamure M, Cohen JM, Pribil C, Garassus P, Auray J, Fleming D, Pujol P. Impact of Influenza B in France. Value Health 2014;17(7):A554; PMID:27201811; http://dx.doi.org/10.1016/j.jval.2014.08.1818
   Google Scholar
• Silva ML, Perrier L, Späth HM, Grog I, Mosnier A, Havet N, Cohen JM; IBGP team. Economic burden of seasonal influenza B in France during winter 2010-2011. BMC Public Health 2014;14:56; PMID:24443900; http://dx.doi.org/10.1186/1471-2458-14-56
   Google Scholar
• Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-8; PMID:22226861; http://dx.doi.org/10.1016/j.vaccine.2011.12.098
   PubMed Web of Science ®Google Scholar
• Crepey P, de Boer PT, Postma MJ, Pitman R. Retrospective public health impact of a quadrivalent influenza vaccine in the United States. Influenza Other Respir Viruses 2015; 9 (Suppl 1):39-46; PMID:26256294; http://dx.doi.org/10.1111/irv.12318
   PubMed Web of Science ®Google Scholar
• Van Bellinghen LA, Meier G, Van Vlaenderen I. The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model. PLoS One 2014; 9:e98437; PMID:24905235; http://dx.doi.org/10.1371/journal.pone.0098437
   PubMed Web of Science ®Google Scholar
• Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States. Hum Vaccin Immunother 2014; 10:1171-80; PMID:24609063; http://dx.doi.org/10.4161/hv.28221
   PubMed Web of Science ®Google Scholar
• Reingold L. Proposed Revisions to the 2005 WHO Position Paper on Influenza Vaccines. 2012.
   Google Scholar
• Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season. MMWR Morb Mortal Wkly Rep 2015; 64:818-25; PMID:26247435; http://dx.doi.org/10.15585/mmwr.mm6430a3
   PubMed Web of Science ®Google Scholar
• Eichner M, Schwehm M, Hain J, Uphoff H, Salzberger B, Knuf M, Schmidt-Ott R. 4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany. BMC Infect Dis 2014; 14:365; PMID:24993051; http://dx.doi.org/10.1186/1471-2334-14-365
   PubMed Web of Science ®Google Scholar
• Lee BY, Bartsch SM, Willig AM. The economic value of a quadrivalent versus trivalent influenza vaccine. Vaccine 2012; 30:7443-6; PMID:23084849; http://dx.doi.org/10.1016/j.vaccine.2012.10.025
   PubMed Web of Science ®Google Scholar
• Meier G, Gregg M, Poulsen Nautrup B. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the UK. J Med Econ 2015; 18:746-61; PMID:25903831; http://dx.doi.org/10.3111/13696998.2015.1044456
   PubMed Web of Science ®Google Scholar
• Duru G, Carrat F, Pribil C, Bricaire F, Pujol P, Robert J, Lafuma A. Cost Effectiveness of Quadrivalent Influenza Vaccine Over Trivalent Vaccine in France. Value Health 2014;17(7):A678; PMID:27202501; http://dx.doi.org/10.1016/j.jval.2014.08.2525
   Google Scholar
• Quinn E, Jit M, Newall AT. Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination. Expert Rev Pharmacoecon Outcomes Res 2014; 14:425-35; PMID:24734967; http://dx.doi.org/10.1586/14737167.2014.908713
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Denis M, Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012; 31:49-57; PMID:23142300; http://dx.doi.org/10.1016/j.vaccine.2012.10.084
   PubMed Web of Science ®Google Scholar
• Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 2013; 11:153; PMID:23800265; http://dx.doi.org/10.1186/1741-7015-11-153
   PubMed Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010; 2010:CD004876.
   Google Scholar
• Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008:CD004879; PMID:18425905
   PubMed Web of Science ®Google Scholar
• Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2011; 12:36-44; PMID:22032844; http://dx.doi.org/10.1016/S1473-3099(11)70295-X
   PubMed Web of Science ®Google Scholar
• Influenza in Canada 2010–2011 season. Public health agency of canada, 2013
   Google Scholar
• Eurostat. Your Key to European Statistics. 2013. Available from: http://ec.europa.eu/eurostat. (Last access: 03/12/2014).
   Google Scholar
• ECDC SIIP Team. Priority risk groups for Influenza vaccination. Available from: http://ecdc.europa.eu/en/publications/Publications/0808_GUI_Priority_Risk_Groups_for_Influenza_Vaccination.pdf. (Last access: 11/24/2015).
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Influenza activity--United States and worldwide, 2007-08 season. MMWR Morb Mortal Wkly Rep 2008; 57(25):692-7; PMID:18583957.
   Google Scholar
• European Centre for Disease Prevention and Control. European Influenza Surveillance Network (EISN). Available at: http://ecdc.europa.eu/en/healthtopics/influenza/EISN/Pages/index.aspx. (Last access: 11/24/2015).
   Google Scholar
• European Centre for Disease Prevention and Control. Influenza virus characterisation, May 2013. Available at: http://ecdc.europa.eu/en/publications/Publications/influenza-virus-characterisation-may-2013.pdf. (Last access: 03/12/2014).
   Google Scholar